Hanjaya Mandala Sampoerna Tbk PT (HMSP)
Jakarta Exchange · Indonesia · prices in IDR · close of 23 Oct 2026
Key indicators
| Last close | IDR 650.00 |
|---|---|
| 52-week range | 570.00 – 1,000.00 |
| Return, 1 month / 3 months | +0.8% / −10.3% |
| Return, 1 year / 3 years | −9.8% / −2.1% |
| Trend | Below its 200-day average |
| RSI (14) | 52 |
| Volatility (1 year) | 37.5% |
| Worst drawdown (1 year) | -31.7% |
| Average daily value traded | 13,103.65M IDR |
| Dividend yield | 8.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hanjaya Mandala Sampoerna is an Indonesian tobacco company based in Surabaya. It makes kretek cigarettes, which blend tobacco with cloves, and sells them under brands such as Dji Sam Soe and A Mild. Its customers are adult smokers across Indonesia, where kretek cigarettes are a common part of the market. The company also operates its own distribution network to move its products to retailers and outlets throughout the country.
The shares are listed on the Jakarta Exchange in Indonesia under the code HMSP, and the price on this page is in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hanjaya Mandala Sampoerna Tbk PT (HMSP) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 650.00 on 23 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 156 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 9.8% and over the last three months it fell 10.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 60 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -7.3% | ||
| From 52-week high | -30.5% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.3% | ||
| 6-month return | -4.9% | ||
| 12-month return, skipping the last month | -10.4% | ||
| Stability (higher is calmer) | 80 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 37.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.7% | ||
| Liquidity | 85 · Strong | Trades actively. | |
| Average daily value traded | 13,103.65M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | 76 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 8.7% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +6.6% |
|---|---|
| 1 month | +0.8% |
| 3 months | −10.3% |
| 6 months | −4.9% |
| 1 year | −9.8% |
| 3 years | −2.1% |
| 5 years | −15.4% |
Signals
| 50-day / 200-day average | 679.80 / 701.26 |
|---|---|
| Golden / death cross (60 days) | Death, 10 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 26.05 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 May 2026 | IDR 56.3000 |
| 11 Jun 2025 | IDR 56.2000 |
| 3 May 2024 | IDR 69.3000 |
| 20 Jun 2023 | IDR 54.7000 |
| 20 Jun 2022 | IDR 63.3000 |
| 8 Jun 2021 | IDR 72.8000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.